Viewing Study NCT06055361


Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2026-01-31 @ 7:32 AM
Study NCT ID: NCT06055361
Status: RECRUITING
Last Update Posted: 2025-09-19
First Post: 2023-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Sponsor: Brexogen Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atopic dermatitis View
None exosome View
None extracellular vesicles View
None EV View